![Reticulocytosis as a Surrogate Marker of Recent Pf Malaria Infection: Association with Clinical, Parasitological and Haematological outcomes: Okoth, Patrick: 9783845437156: Amazon.com: Books Reticulocytosis as a Surrogate Marker of Recent Pf Malaria Infection: Association with Clinical, Parasitological and Haematological outcomes: Okoth, Patrick: 9783845437156: Amazon.com: Books](https://m.media-amazon.com/images/I/71D3QcR0ZUS._AC_UF1000,1000_QL80_.jpg)
Reticulocytosis as a Surrogate Marker of Recent Pf Malaria Infection: Association with Clinical, Parasitological and Haematological outcomes: Okoth, Patrick: 9783845437156: Amazon.com: Books
![LEFT ATRIAL STRAIN AS A SURROGATE MARKER OF ATRIAL CHAMBER STIFFNESS | Journal of the American College of Cardiology LEFT ATRIAL STRAIN AS A SURROGATE MARKER OF ATRIAL CHAMBER STIFFNESS | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/e45df9a8-8f5c-4853-ab89-59d9bbf3a364/s0735-1097(19)32132-1.fp.png)
LEFT ATRIAL STRAIN AS A SURROGATE MARKER OF ATRIAL CHAMBER STIFFNESS | Journal of the American College of Cardiology
![Controlling HgBA1C with Medications Does not Make Diabetes Disappear - It Lowers the Surrogate Marker HgBA1C - APIM Controlling HgBA1C with Medications Does not Make Diabetes Disappear - It Lowers the Surrogate Marker HgBA1C - APIM](https://worldlinkmedical-uploads.azureedge.net/worldlinkmedical/2021/08/HbA1c-Test-Resized.png)
Controlling HgBA1C with Medications Does not Make Diabetes Disappear - It Lowers the Surrogate Marker HgBA1C - APIM
![Endpoints for geroscience clinical trials: health outcomes, biomarkers, and biologic age | SpringerLink Endpoints for geroscience clinical trials: health outcomes, biomarkers, and biologic age | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11357-022-00671-8/MediaObjects/11357_2022_671_Fig1_HTML.png)
Endpoints for geroscience clinical trials: health outcomes, biomarkers, and biologic age | SpringerLink
Information Theory–Based Surrogate Marker Evaluation from Several Randomized Clinical Trials with Binary Endpoints, Using SAS: Journal of Biopharmaceutical Statistics: Vol 18, No 2
![Cardiovascular surrogate markers and cardiometabolic therapeutics: a viewpoint learned from clinical trials on dipeptidyl peptidase-4 inhibitors | Cardiovascular Diabetology | Full Text Cardiovascular surrogate markers and cardiometabolic therapeutics: a viewpoint learned from clinical trials on dipeptidyl peptidase-4 inhibitors | Cardiovascular Diabetology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12933-021-01234-5/MediaObjects/12933_2021_1234_Fig1_HTML.png)
Cardiovascular surrogate markers and cardiometabolic therapeutics: a viewpoint learned from clinical trials on dipeptidyl peptidase-4 inhibitors | Cardiovascular Diabetology | Full Text
![Pulsatile energy consumption as a surrogate marker for vascular afterload improves with time post transcatheter aortic valve replacement in patients with aortic stenosis | Hypertension Research Pulsatile energy consumption as a surrogate marker for vascular afterload improves with time post transcatheter aortic valve replacement in patients with aortic stenosis | Hypertension Research](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41440-022-01127-4/MediaObjects/41440_2022_1127_Figa_HTML.png)
Pulsatile energy consumption as a surrogate marker for vascular afterload improves with time post transcatheter aortic valve replacement in patients with aortic stenosis | Hypertension Research
![2 Relationship between a surrogate marker and true outcome, adjusted... | Download Scientific Diagram 2 Relationship between a surrogate marker and true outcome, adjusted... | Download Scientific Diagram](https://www.researchgate.net/publication/40798768/figure/fig7/AS:408360974340102@1474372251459/Relationship-between-a-surrogate-marker-and-true-outcome-adjusted-for-this-thesis-28.png)
2 Relationship between a surrogate marker and true outcome, adjusted... | Download Scientific Diagram
![Cancers | Free Full-Text | Splenic Volume as a Surrogate Marker of Immune Checkpoint Inhibitor Efficacy in Metastatic Non Small Cell Lung Cancer Cancers | Free Full-Text | Splenic Volume as a Surrogate Marker of Immune Checkpoint Inhibitor Efficacy in Metastatic Non Small Cell Lung Cancer](https://www.mdpi.com/cancers/cancers-13-03020/article_deploy/html/images/cancers-13-03020-g001.png)
Cancers | Free Full-Text | Splenic Volume as a Surrogate Marker of Immune Checkpoint Inhibitor Efficacy in Metastatic Non Small Cell Lung Cancer
![REBEL Cast Episode 1: Clinically Important Biphasic Anaphylaxis & Total Lymphocyte Count as a Surrogate Marker for CD4 - REBEL EM - Emergency Medicine Blog REBEL Cast Episode 1: Clinically Important Biphasic Anaphylaxis & Total Lymphocyte Count as a Surrogate Marker for CD4 - REBEL EM - Emergency Medicine Blog](https://rebelem.com/wp-content/uploads/2014/07/REBEL-Cast-Episode-1-1024x575.png)